Post Profile

Hepatocellular carcinoma: Resection vs. transplantation

(Deutsches Aerzteblatt International) Liver transplantation is the gold standard for treating early hepatocellular cancers. Because of the lack of donors, this option is, however, available to a limited degree only. Curative liver resection is an alternative in this setting. Markus B. Schoenberg, Julian N. Bucher, and coauthors investigated whether liver resection can yield results that are comparable to those of liver transplantation.
read more


Related Posts

Scientists Fish For Answers About Hepatocellular Carcinoma

Health : Medical News Today

Hepatocellular carcinoma (HCC), the most common type of liver cancer, is a leading cause of cancer-related deaths worldwide. Although there are several treatment options available, they are largely unsuccessful because the disease i...

Liver Tumor Growth in Mice Slowed with New Chemo-Immunotherapy Treatment

Health : Newswise Medical News

Hepatocellular carcinoma is the most common form of liver cancer, but treatment options are limited and many patients are diagnosed in late stages when the disease can't be treated. Now, University of Missouri School of Medicine res...

Living With Cancer: Hepatocellular carcinoma

Health : Mayo Clinic News Blog

Hepatocellular carcinoma Hepatocellular carcinoma is the most common type of primary liver cancer. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatiti...

FDA Approves New Drug to Treat Hepatocellular Carcinoma, the Most Common Form of Liver Cancer

Health : Newswise Medical News

The U.S. Food & Drug Administration today approved a new drug to treat people with hepatocellular carcinoma, the most common form of liver cancer. The drug, regorafenib, is the first and only therapy approved by the FDA in over a de...

Successful phase 3 trial of drug for liver cancer

Diseases & Conditions / Cancer : ScienceDaily: Cancer

An international phase 3 trial has found that the drug regorafenib improved survival in patients with advanced hepatocellular carcinoma, a form of liver cancer, giving people who previously had no other options a better chance at su...


Copyright © 2016 Regator, LLC